AF710B, an M1/sigma‐1 receptor agonist with long‐lasting disease‐modifying properties in a transgenic rat model of Alzheimer's disease-Reference-Cited by-同舟云学术

AF710B, an M1/sigma‐1 receptor agonist with long‐lasting disease‐modifying properties in a transgenic rat model of Alzheimer's disease

Published:2017-12-29 Issue:6 Volume:14 Page:811-823
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hall Hélène¹,Iulita Maria Florencia¹,Gubert Palma¹,Flores Aguilar Lisi²,Ducatenzeiler Adriana¹,Fisher Abraham³,Cuello Augusto Claudio¹²⁴

Affiliation:

1. Department of Pharmacology and TherapeuticsMcGill UniversityMontrealCanada

2. Department of Anatomy and Cell BiologyMcGill UniversityMontrealCanada

3. Department of Medicinal ChemistryIsrael Institute for Biological ResearchNess ZionaIsrael

4. Department of Neurology and NeurosurgeryMcGill UniversityMontrealCanada

Funder

Canadian Institutes of Health Research

Fonds de Recherche du Québec - Santé

Fonds de Recherche du Québec - Nature et Technologies

Canadian Institute of Health and Research

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.11.009

Reference83 articles.

1. The Cholinergic Hypothesis of Geriatric Memory Dysfunction

2. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

3. NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES

4. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

5. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive and Histopathological Alterations in Rat Models of Early- and Late-Phase Memory Dysfunction: Effects of Sigma-1 Receptor Activation;Journal of Alzheimer's Disease;2024-09-02

2. Muscarinic Receptors and Alzheimer’s Disease: New Perspectives and Mechanisms;Current Issues in Molecular Biology;2024-07-02

3. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease;Neuropharmacology;2024-01

4. Multi-perspective neural network for dual drug repurposing in Alzheimer’s disease;Knowledge-Based Systems;2024-01

5. Population‐Based Characterization of the Pharmacokinetics and Food Effect of ANAVEX3‐71, a Novel Sigma‐1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer Disease;Clinical Pharmacology in Drug Development;2023-12-10